Sign in

CIK 0001787306

  • Large accelerated filer

Arcutis Biotherapeutics, Inc.

Sign in to watch
Ticker
ARQT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812974255
Phone
+1 805-418-5006
Business address
3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
Former names
Arcutis, Inc.
  1. 4 Open-market buy Watanabe Todd Franklin bought 6,038 shares at an average $3.52 ($21,250)
  2. 4 Open-market sale Burnett Patrick sold 16,023 shares at $10.14 ($162,515)
  3. 4 Planned sale Matsuda Masaru sold 1,775 shares at $9.68 ($17,190)
  4. 4 Open-market sale Burnett Patrick sold 69,226 shares at an average $10.29 ($712,621)
  5. 4 Open-market sale Director sold 8,687 shares at $10.85 ($94,238)
  6. 4 Planned sale Matsuda Masaru sold 5,015 shares at $8.68 ($43,551)
  7. 4 Planned sale Watanabe Todd Franklin sold 13,871 shares at $8.68 ($120,459)
  8. 4 Planned sale Director sold 10,000 shares at $8.65 ($86,541)
  9. 4 Planned sale Burnett Patrick sold 15,441 shares at $8.68 ($134,093)
  10. 4 Planned sale Director sold 10,000 shares at $9.26 ($92,616)
  11. 4 Planned sale SVP Chief Commercial Officer sold 3,725 shares at $10.01 ($37,295)
  12. 4 Open-market sale Chief Financial Officer sold 11,626 shares at $9.48 ($110,264)
  13. 4 Planned sale Director sold 10,000 shares at $10.77 ($107,695)
  14. 4 Planned sale Burnett Patrick sold 1,728 shares at $8.29 ($14,318)
  15. 4 Planned sale Matsuda Masaru sold 5,220 shares at $9.02 ($47,064)
  16. 4 Planned sale Burnett Patrick sold 13,206 shares at $9.02 ($119,106)
  17. 4 Planned sale Watanabe Todd Franklin sold 14,487 shares at $9.02 ($130,648)
  18. 4 Planned sale Director sold 10,000 shares at $9.87 ($98,696)
  19. 4 Planned sale Director sold 10,000 shares at $9.31 ($93,141)
  20. 4 Grant or award Director acquired 10,139 shares (grant or award)

Page 8 of 23 · 452 filings